Anita Anand, Canada's Minister of Public Services and Procurement opens a box with some of the AstraZeneca COVID-19 vaccine doses that Canada has secured through a deal with the Serum Institute of India in partnership with Verity Pharma at a facility in M

COVID-19

PRI audio player

Biolyse’s unconventional move to try to produce single-dose COVID-19 vaccines adds to a fierce global debate about who controls vaccine knowledge and production in a pandemic.

Player utilities

Read the full story at TheWorld.org.

Canada's Minister of Public Services and Procurement Anita Anand opens a box with some of the AstraZeneca COVID-19 vaccine doses that Canada has secured through a deal with the Serum Institute of India in partnership with Verity Pharma at a facility in Milton, Ontario, March 3, 2021.

Credit:

Carlos Osorio/Pool photo via AP 

Related Stories

close

We use cookies to understand how you use our site and to improve your experience. To learn more, review our Cookie Policy. By continuing to use our site, you accept our use of cookies and Privacy Policy.

Ok, I understand. Close
close

The story you just read is freely available and accessible to everyone because readers like you support The World financially. 

Thank you all for helping us reach our goal of 1,000 donors. We couldn’t have done it without your support. Your donation directly supported the critical reporting you rely on, the consistent reporting you believe in, and the deep reporting you want to ensure survives. 

DONATE TODAY > No thanks